# Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo

> **NCT04775979** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 20 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** diphenylcyclopropenone (DPCP)

## Key facts

- **NCT ID:** NCT04775979
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-17
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04775979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04775979, "Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04775979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*